Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

There are always new bike bits, bobs, products, and gear to share. This week in tech news comes all over the spectrum of ...

FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...

We are focused on the potential FDA approval for CARDAMYST and the opportunity to help the millions of patients suffering from PSVT,” said ...

Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.

A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

The patient, a man in his 40s from New South Wales, received the BiVACOR Total Artificial Heart (TAH) during a six-hour ...

A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders.

The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.